Added to YB: 2025-02-05
Pitch date: 2025-02-04
DERM [bullish]
Journey Medical Corporation
+43.66%
current return
Author Info
The 10x Radar shares high-conviction small and microcap stock pitches with the potential to deliver multi-bagger returns. Sign up for the newsletter.
Company Info
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$201.1M
Pitch Price
$5.36
Price Target
15.00 (+96%)
Dividend
N/A
EV/EBITDA
-165.92
P/E
-19.72
EV/Sales
3.39
Sector
Pharmaceuticals
Category
growth
Journey Medical: A Small-Cap Multibagger Hiding in Plain Sight
DERM: FDA-approved Emrosi for rosacea, launching 2025. Potential to capture 25-30% of $300M Oracea market by 2027. Profitable base biz, $55M rev. Strong sales team, 80% coverage. Risks: generic competition, launch execution. $4.50/share, 3-4x upside potential to $15 by 2027.
Read full article (5 min)